Brian Goff

Chief Executive Officer

Brian Goff (Chief Executive Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Agios Pharmaceuticals, Inc. (AGIO). The largest single filing was $662K of AGIO (19,068 sh across 2 lots, as filed), executed Apr 2.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.7M

shares × price, as filed

Last traded

Apr 2

Filed Apr 6

Median ADV $39.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

AGIO

Agios Pharmaceuticals, Inc. AGIO · 0 buys · 6 sells 6 filings

Recent filings

AGIOSALE Agios Pharmaceuticals, Inc. View filing → $662K
19,068 sh across 2 lots
Exec Apr 2
Filed Apr 6 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $523K
18,055 sh across 3 lots
Exec Mar 2
Filed Mar 3 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $507K
18,703 sh across 2 lots
Exec Dec 30 2025
Filed Jan 2 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $406K
11,085 sh × $36.67
Exec Aug 8 2025
Filed Aug 12 2025 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $627K
18,700 sh across 2 lots
Exec Jun 24 2025
Filed Jun 26 2025 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $460K
12,947 sh across 2 lots
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET